Clinical trial
Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation
NCT00903929 is registered in ClinicalTrials.gov with Jane Liesveld as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation
- Lead sponsor
- Jane Liesveld
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- December 31, 2015
- Enrollment
- 19 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.